189 related articles for article (PubMed ID: 17228880)
21. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
[TBL] [Abstract][Full Text] [Related]
22. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637
[TBL] [Abstract][Full Text] [Related]
23. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
[TBL] [Abstract][Full Text] [Related]
24. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterisation of the adenosine receptor mediating increased ion transport in the mouse isolated trachea and the effect of allergen challenge.
Kornerup KN; Page CP; Moffatt JD
Br J Pharmacol; 2005 Apr; 144(7):1011-6. PubMed ID: 15685200
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
[TBL] [Abstract][Full Text] [Related]
27. New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Varani K; Borea PA
J Med Chem; 2005 Jul; 48(15):5001-8. PubMed ID: 16033279
[TBL] [Abstract][Full Text] [Related]
28. 2-Phenylhydroxypropynyladenosine derivatives as high potent agonists at A2B adenosine receptor subtype.
Lambertucci C; Volpini R; Costanzi S; Taffi S; Vittori S; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):809-12. PubMed ID: 14565284
[TBL] [Abstract][Full Text] [Related]
29. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor.
Johansson S; Fredholm BB; Hjort C; Morein T; Kull B; Hu PS
Biochem Pharmacol; 2005 Aug; 70(4):598-605. PubMed ID: 15979585
[TBL] [Abstract][Full Text] [Related]
30. 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
Cristalli G; Volpini R; Vittori S; Camaioni E; Monopoli A; Conti A; Dionisotti S; Zocchi C; Ongini E
J Med Chem; 1994 May; 37(11):1720-6. PubMed ID: 8201607
[TBL] [Abstract][Full Text] [Related]
31. Structural Characterization of Agonist Binding to an A
Stamatis D; Lagarias P; Barkan K; Vrontaki E; Ladds G; Kolocouris A
J Med Chem; 2019 Oct; 62(19):8831-8846. PubMed ID: 31502843
[TBL] [Abstract][Full Text] [Related]
32. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
[TBL] [Abstract][Full Text] [Related]
33. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
[TBL] [Abstract][Full Text] [Related]
34. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
[TBL] [Abstract][Full Text] [Related]
35. A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.
Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Roerink SF; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
J Med Chem; 2005 Mar; 48(6):2045-53. PubMed ID: 15771447
[TBL] [Abstract][Full Text] [Related]
36. A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.
Vittori S; Costanzi S; Lambertucci C; Portino FR; Taffi S; Volpini R; Klotz KN; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):471-81. PubMed ID: 15043167
[TBL] [Abstract][Full Text] [Related]
37. Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding.
Priego EM; Pérez-Pérez MJ; von Frijtag Drabbe Kuenzel JK; de Vries H; Ijzerman AP; Camarasa MJ; Martín-Santamaría S
ChemMedChem; 2008 Jan; 3(1):111-9. PubMed ID: 18000937
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Adachi H; Palaniappan KK; Ivanov AA; Bergman N; Gao ZG; Jacobson KA
J Med Chem; 2007 Apr; 50(8):1810-27. PubMed ID: 17378544
[TBL] [Abstract][Full Text] [Related]
39. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
[TBL] [Abstract][Full Text] [Related]
40. 8-Substituted-9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B.
Carotti A; Stefanachi A; Raviña E; Sotelo E; Loza MI; Cadavid MI; Centeno NB; Nicolotti O
Eur J Med Chem; 2004 Oct; 39(10):879-87. PubMed ID: 15464622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
